Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology.

Bayer AC, Sanmarco LM, Pellerin A, Masi G, Plasencia A, Anderson JM, Nowak RJ, Damato V, Massacesi L, Pham MC, Khani-Habibabadi F, Vital H, Higginson-Scott N, Otipoby KL, Xing Y, Mascanfroni ID, O'Connor KC

Open source

DOI
10.1073/pnas.2505984122
Published
2025 Oct 28
Container
Proceedings of the National Academy of Sciences of the United States of America
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1073/pnas.2505984122,
  title = {Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology.},
  author = {Bayer AC and Sanmarco LM and Pellerin A and Masi G and Plasencia A and Anderson JM and Nowak RJ and Damato V and Massacesi L and Pham MC and Khani-Habibabadi F and Vital H and Higginson-Scott N and Otipoby KL and Xing Y and Mascanfroni ID and O'Connor KC},
  year = {2025},
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  doi = {10.1073/pnas.2505984122},
  url = {https://doi.org/10.1073/pnas.2505984122}
}

RIS

TY  - JOUR
TI  - Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology.
AU  - Bayer AC
AU  - Sanmarco LM
AU  - Pellerin A
AU  - Masi G
AU  - Plasencia A
AU  - Anderson JM
AU  - Nowak RJ
AU  - Damato V
AU  - Massacesi L
AU  - Pham MC
AU  - Khani-Habibabadi F
AU  - Vital H
AU  - Higginson-Scott N
AU  - Otipoby KL
AU  - Xing Y
AU  - Mascanfroni ID
AU  - O'Connor KC
PY  - 2025
JO  - Proceedings of the National Academy of Sciences of the United States of America
DO  - 10.1073/pnas.2505984122
UR  - https://doi.org/10.1073/pnas.2505984122
ER  - 

APA

AC, B., LM, S., A, P., G, M., A, P., JM, A., RJ, N., V, D., L, M., MC, P., F, K., H, V., N, H., KL, O., Y, X., ID, M., & KC, O. (2025). Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology.. Proceedings of the National Academy of Sciences of the United States of America. https://doi.org/10.1073/pnas.2505984122

Source records